128 related articles for article (PubMed ID: 6500507)
21. Delta hepatitis in Malaysia.
Sinniah M; Dimitrakakis M; Tan DS
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
[TBL] [Abstract][Full Text] [Related]
22. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
23. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
Loeschke K; Abb J; Farack UM; Wiebecke B
Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus.
Nath N; Mushahwar IK; Fang CT; Berberian H; Dodd RY
Am J Epidemiol; 1985 Aug; 122(2):218-25. PubMed ID: 4014206
[TBL] [Abstract][Full Text] [Related]
25. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
Calzia R; Ciravegna B; Navone C; Tolentino P
Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
Rizzetto M; Purcell RH; Gerin JL
Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
[TBL] [Abstract][Full Text] [Related]
28. [Markers of HBV infection in drug addicts].
Laskus T; Radkowski M; Werezyńska T; Horban A; Lupa E; Cianciara J; Slusarczyk J
Pol Arch Med Wewn; 1992 Feb; 87(2):104-11. PubMed ID: 1523136
[TBL] [Abstract][Full Text] [Related]
29. Nosocomial transmission of delta hepatitis.
Lettau LA; Alfred HJ; Glew RH; Fields HA; Alter MJ; Meyer R; Hadler SC; Maynard JE
Ann Intern Med; 1986 May; 104(5):631-5. PubMed ID: 3963662
[TBL] [Abstract][Full Text] [Related]
30. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
[TBL] [Abstract][Full Text] [Related]
31. Serological markers of hepatitis A and B virus infection in university students.
Nakamura S
Tohoku J Exp Med; 1982 Oct; 138(2):237-8. PubMed ID: 6294917
[TBL] [Abstract][Full Text] [Related]
32. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
[TBL] [Abstract][Full Text] [Related]
33. Multiple hepatitis attacks in drug addicts.
Norkrans G; Frösner G; Hermodsson S; Iwarson S
JAMA; 1980 Mar; 243(10):1056-8. PubMed ID: 6766507
[TBL] [Abstract][Full Text] [Related]
34. Significance of antibody to hepatitis Be antigen (anti-HBe) in HBsAg-negative individuals.
Hess G; Arnold W; Gahl GM; Vogl E; Meyer zum Büschenfelde KH
Vox Sang; 1981 Feb; 40(2):95-8. PubMed ID: 7233888
[TBL] [Abstract][Full Text] [Related]
35. Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience.
Shiels MT; Czaja AJ; Taswell HF; Gerin JL; Purcell RH; Ludwig J; Rakela J; Nelson CA
Gastroenterology; 1985 Dec; 89(6):1230-4. PubMed ID: 4054516
[TBL] [Abstract][Full Text] [Related]
36. Detection of hepatitis B viral DNA in sera positive for antibody to delta antigen.
Theilmann L; Gmelin K; Will H; Czygan P; Roggendorf M; Kommerell B
J Infect Dis; 1984 Jul; 150(1):118-20. PubMed ID: 6747341
[TBL] [Abstract][Full Text] [Related]
37. Clinical, epidemiological and prognostic aspects of hepatitis "non-A, non-B"--a comparison with hepatitis A and B.
Norkrans G; Frösner G; Hermodsson S; Iwarson S
Scand J Infect Dis; 1979; 11(4):259-64. PubMed ID: 119311
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis D virus infection in children with acute or chronic hepatitis B virus infection in Taiwan.
Hsu HY; Chang MH; Chen DS; Lee CY
J Pediatr; 1988 Jun; 112(6):888-92. PubMed ID: 3373392
[TBL] [Abstract][Full Text] [Related]
39. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
40. Anti-HIV and anti-HBc antibodies and HBsAg in postmortem blood of drug addicts: the picture for 1988.
Tappero P; Merlino C; Angeretti A; Cavallo R; Vai S; Negro Ponzi A
Panminerva Med; 1989; 31(3):137-9. PubMed ID: 2601978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
